Beau Ballard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Beau Ballard has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Michael Ernst Fassbender
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
11 shared publications - Kevin D. John
Los Alamos National Laboratory, Los Alamos, NM 87545, USA
9 shared publications - Francois M. Nortier
Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, United States
8 shared publications E.R. Birnbaum
5 shared publications- Jonathan W. Engle
University of Wisconsin−Madison
4 shared publications A. Couture
3 shared publications
Latest Publications
- 1 May 2014
- Published by Elsevier in Journal of Chromatography A
- Vol. 1340, 109-114
Chromatographic separation of selenium and arsenic: A potential 72Se/72As generator
- 1 May 2014
- Published by Elsevier in Journal of Chromatography A
- Vol. 1340, 109-114
Chromatographic separation of selenium and arsenic: A potential 72Se/72As generator
- 4 April 2014
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 102 (7) , 569-581
Ac, La, and Ce radioimpurities in 225Ac produced in 40–200 MeV proton irradiations of thorium
Accelerator production of 225Ac addresses the global supply deficiency currently inhibiting clinical trials from establishing 225Ac's therapeutic utility, provided that the accelerator product is of sufficient radionuclidic purity for patient use. Two proton activation experiments utilizing the stacked foil technique between 40 and 200 MeV were employed to study the likely co-formation of radionuclides expected to be especially challenging to separate from 225Ac. Foils were assayed by nondestructive γ-spectroscopy and by α-spectroscopy of chemically processed target material. Nuclear formation cross sections for the radionuclides 226Ac and 227Ac as well as lower lanthanide radioisotopes 139Ce, 141Ce, 143Ce, and 140La whose elemental ionic radii closely match that of actinium were measured and are reported. The predictions of the latest MCNP6 event generators are compared with measured data, as they permit estimation of the formation rates of other radionuclides whose decay emissions are not clearly discerned in the complex spectra collected from 232Th(p,x) fission product mixtures.
- 4 April 2014
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 102 (7) , 569-581
Ac, La, and Ce radioimpurities in 225Ac produced in 40–200 MeV proton irradiations of thorium
Accelerator production of 225Ac addresses the global supply deficiency currently inhibiting clinical trials from establishing 225Ac's therapeutic utility, provided that the accelerator product is of sufficient radionuclidic purity for patient use. Two proton activation experiments utilizing the stacked foil technique between 40 and 200 MeV were employed to study the likely co-formation of radionuclides expected to be especially challenging to separate from 225Ac. Foils were assayed by nondestructive γ-spectroscopy and by α-spectroscopy of chemically processed target material. Nuclear formation cross sections for the radionuclides 226Ac and 227Ac as well as lower lanthanide radioisotopes 139Ce, 141Ce, 143Ce, and 140La whose elemental ionic radii closely match that of actinium were measured and are reported. The predictions of the latest MCNP6 event generators are compared with measured data, as they permit estimation of the formation rates of other radionuclides whose decay emissions are not clearly discerned in the complex spectra collected from 232Th(p,x) fission product mixtures.
- 14 March 2014
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 102 (4) , 325-332
Radiochemical Study of Re/W Adsorption Behavior on a Strongly Basic Anion Exchange Resin
Rhenium-186g is a radionuclide with a high potential for therapeutic applications. It emits therapeutic β − particles accompanied by low energy γ-rays, which allows for in-vivo tracking of the radiolabeled compound and dosimetry estimates. The current reactor production pathway 185Re(n, γ)186gRe produces low specific activity 186gRe, thereby limiting its therapeutic application. Work is underway to develop an accelerator-based, charged particle induced production method for high specific activity 186gRe from targets of enriched 186W. To optimize the chemical 186gRe recovery method, batch studies have been performed to characterize the adsorption behavior of Re and W on a strongly basic anion exchange resin. An in-depth physicochemical profile was developed for the interaction of Re with resin material, which showed the reaction to be endothermic and spontaneous. Basic (NaOH) and acidic (HNO3) matrices were used to determine the equilibrium distribution coefficients for Re and W. The resin exhibits the best affinity for Re at slightly basic conditions and little affinity above moderately acidic concentrations. Tungsten has low affinity for the resin above moderately basic concentrations. A study was performed to examine the effect of W concentration on Re adsorption, which showed that even a high ionic WO4 2– strength of up to 1.9 mol kg –1 does not significantly compromise ReO4 – retention on the resin.
- 14 March 2014
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 102 (4) , 325-332
Radiochemical Study of Re/W Adsorption Behavior on a Strongly Basic Anion Exchange Resin
Rhenium-186g is a radionuclide with a high potential for therapeutic applications. It emits therapeutic β − particles accompanied by low energy γ-rays, which allows for in-vivo tracking of the radiolabeled compound and dosimetry estimates. The current reactor production pathway 185Re(n, γ)186gRe produces low specific activity 186gRe, thereby limiting its therapeutic application. Work is underway to develop an accelerator-based, charged particle induced production method for high specific activity 186gRe from targets of enriched 186W. To optimize the chemical 186gRe recovery method, batch studies have been performed to characterize the adsorption behavior of Re and W on a strongly basic anion exchange resin. An in-depth physicochemical profile was developed for the interaction of Re with resin material, which showed the reaction to be endothermic and spontaneous. Basic (NaOH) and acidic (HNO3) matrices were used to determine the equilibrium distribution coefficients for Re and W. The resin exhibits the best affinity for Re at slightly basic conditions and little affinity above moderately acidic concentrations. Tungsten has low affinity for the resin above moderately basic concentrations. A study was performed to examine the effect of W concentration on Re adsorption, which showed that even a high ionic WO4 2– strength of up to 1.9 mol kg –1 does not significantly compromise ReO4 – retention on the resin.
- 1 March 2014
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 41 (3) , 276-281
166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: Comparison with 188Re radiolabel
- 1 March 2014
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 41 (3) , 276-281
166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: Comparison with 188Re radiolabel
- 28 January 2013
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 101 (5) , 339-346
Proton irradiation parameters and chemical separation procedure for the bulk production of high-specific-activity 186gRe using WO3 targets
Rhenium-186g (T 1/2= 89.2 h) is a β − emitter suitable for therapeutic applications. Current production methods rely on reactor production via 185Re(n,γ) which results in low specific activities, thereby limiting its use. Production by p,d activation of enriched 186W results in a 186gRe product with a higher specific activity, allowing it to be used for targeted therapy with limited receptors. A test target consisting of pressed, sintered natWO3 was proton irradiated at Los Alamos (LANL-IPF) to evaluate product yield and impurities, irradiation parameters and wet chemical Re recovery for proof-of-concept for bulk production of 186gRe. We demonstrated isolation of 186gRe in 97% yield from irradiated natWO3 targets within 12 h of end of bombardment (EOB) via an alkaline dissolution followed by anion exchange. The recovery process has potential for automation, and WO3 can be easily recycled for recurrent irradiations. A 186gRe batch yield of 42.7 ± 2.2 μCi/μAh or 439 ± 23 MBq/C was obtained after 24 h in an 18.5 μA proton beam. The target entrance energy was determined to be 15.6 MeV. The specific activity of 186gRe at EOB was measured to be 1.9 kCi (70.3 TBq) mmol−1, which agrees well with the result of a previous 185,186mRe co-production EMPIRE and TALYS modeling study assuming similar conditions. Utilizing enriched 186WO3, we anticipate that a proton beam of 250 μA for 24 h will provide batch yields of 256 mCi (9.5 GBq) of 186gRe at EOB with specific activities even higher than 1.9 kCi (70.3 TBq) mmol−1, suitable for therapy applications.
- 28 January 2013
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 101 (5) , 339-346
Proton irradiation parameters and chemical separation procedure for the bulk production of high-specific-activity 186gRe using WO3 targets
Rhenium-186g (T 1/2= 89.2 h) is a β − emitter suitable for therapeutic applications. Current production methods rely on reactor production via 185Re(n,γ) which results in low specific activities, thereby limiting its use. Production by p,d activation of enriched 186W results in a 186gRe product with a higher specific activity, allowing it to be used for targeted therapy with limited receptors. A test target consisting of pressed, sintered natWO3 was proton irradiated at Los Alamos (LANL-IPF) to evaluate product yield and impurities, irradiation parameters and wet chemical Re recovery for proof-of-concept for bulk production of 186gRe. We demonstrated isolation of 186gRe in 97% yield from irradiated natWO3 targets within 12 h of end of bombardment (EOB) via an alkaline dissolution followed by anion exchange. The recovery process has potential for automation, and WO3 can be easily recycled for recurrent irradiations. A 186gRe batch yield of 42.7 ± 2.2 μCi/μAh or 439 ± 23 MBq/C was obtained after 24 h in an 18.5 μA proton beam. The target entrance energy was determined to be 15.6 MeV. The specific activity of 186gRe at EOB was measured to be 1.9 kCi (70.3 TBq) mmol−1, which agrees well with the result of a previous 185,186mRe co-production EMPIRE and TALYS modeling study assuming similar conditions. Utilizing enriched 186WO3, we anticipate that a proton beam of 250 μA for 24 h will provide batch yields of 256 mCi (9.5 GBq) of 186gRe at EOB with specific activities even higher than 1.9 kCi (70.3 TBq) mmol−1, suitable for therapy applications.
- 1 November 2012
- Published by Elsevier in Nuclear Physics A
- Vol. 893, 87-100
Cross sections from 800 MeV proton irradiation of terbium
- 1 November 2012
- Published by Elsevier in Nuclear Physics A
- Vol. 893, 87-100
Cross sections from 800 MeV proton irradiation of terbium
- 1 November 2012
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 70 (11) , 2602-2607
Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200MeV
- 1 November 2012
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 70 (11) , 2602-2607
Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200MeV
- 1 November 2012
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 70 (11) , 2590-2595
225Ac and 223Ra production via 800MeV proton irradiation of natural thorium targets
- 1 November 2012
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 70 (11) , 2590-2595
225Ac and 223Ra production via 800MeV proton irradiation of natural thorium targets